ALT |
Alanine aminotransferase |
ANA |
Antinuclear antibodies |
ASS |
Anti-synthetase syndrome |
AST |
Aspartate aminotransferase |
BDI-II |
Beck’s Depression Inventory-II |
CADM |
Clinically amyopathic dermatomyositis |
CG |
Control group |
CK |
Creatine phosphokinase |
CRP |
C-reactive protein |
CXCL10 |
C-X-C motif chemokine ligand 10, also known as IP-10 |
DM |
Dermatomyositis |
ELISA |
Enzyme-linked immunosorbent assay |
ESR |
Erythrocyte sedimentation rate |
FGF |
Fibroblast growth factor |
FI-2 |
Functional Index-2 |
FIS |
Fatigue Impact Scale |
FVA |
Force vector area |
G-CSF |
Granulocyte colony-stimulating factor |
GM-CSF |
Granulocyte-macrophage colony-stimulating factor |
HAQ |
Health Assessment Questionnaire |
HCK |
Hematopoietic cell kinase |
Hsp90 |
Heat shock protein 90 |
IBM |
Inclusion body myositis |
IFN |
Interferon |
IG |
Intervention group |
IIM |
Idiopathic inflammatory myopathies |
IL |
Interleukin |
IMNM |
Immune-mediated necrotizing myopathy |
JAK |
Janus kinase |
LD |
Lactate dehydrogenase |
MAA |
Myositis associated antibodies |
MAPK |
Mitogen-activated protein kinase |
MCP-1 |
Monocyte chemoattractant protein-1, also known as CCL2 |
MIP-1α |
Macrophage inflammatory protein-1α, also known as CCL3 |
MIP-1β |
Macrophage inflammatory protein-1β, also known as CCL4 |
MMT-8 |
Manual Muscle Testing of eight muscle groups |
MSA |
Myositis specific antibodies |
NF-kB |
Nuclear factor kappa-light-chain-enhancer of activated B cells |
OM |
Overlap myositis |
PDGF |
Platelet-derived growth factor |
PM |
Polymyositis |
RANTES |
Regulated on activation/normal T cell expressed and secreted, or CCL5 |
Ras |
Rat sarcoma protein, or Ras GTPase protein |
SF-36 |
Medical Outcomes Study 36-item Short Form Health Survey |
STAT |
Signal transducer and activator of transcription |
TNF |
Tumor necrosis factor |
VEGF |
Vascular endothelial growth factor |
w |
weeks |